ARCHIVES

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

This article is from The Cancer Letter archive.

Vol. 21 No. 18 | May 5, 1995

Download PDF Visit The Full Archive

Related Articles

DRCA Board Okays Concepts For Five Contract Projects

June 25, 1981

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

John Mendelson Says M.D. Anderson Plans to Accelerate Role In Translational Research

May 7, 1999

NCI Nears Confrontation Over Construction As OMB Continues Obstructionist Policies

July 11, 1975

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982

In Brief: FY 1985 Budget Breakdown; Control Gets $64 Million, Construction $6.5; W. VA. $4.5 Maybe

November 9, 1984